XML 73 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
WARRANTS AND OTHER DERIVATIVE LIABILITIES AND FAIR VALUE MEASUREMENTS - (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 14, 2023
USD ($)
item
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Apr. 30, 2023
USD ($)
$ / shares
shares
Feb. 28, 2023
shares
Nov. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
shares
Jun. 15, 2023
$ / shares
Nov. 21, 2022
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares           $ 0.4379            
Warrants exercise price, after reverse stock splits | $ / shares           $ 9,853            
Proceeds from issuance of shares and warrants | $           $ 35,000,000            
Exercised on a cash-less basis           0            
Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares   $ 0.432             $ 0.432      
Warrants exercise price, after reverse stock splits | $ / shares   $ 388.8             388.8      
Proceeds from issuance of shares and warrants | $   $ 45,000,000                    
Warrants issued (in shares)   214,120                    
Securities Purchase Agreement | Scenario one                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares   $ 0.52             0.52      
Warrants exercise price, after reverse stock splits | $ / shares   $ 468             468      
Proceeds from issuance of shares and warrants | $   $ 7,000,000                    
Securities Purchase Agreement | Scenario two                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares   $ 0.1601             0.1601      
Warrants exercise price, after reverse stock splits | $ / shares   $ 144.09             $ 144.09      
Proceeds from issuance of shares and warrants | $                 $ 100,000,000      
Number of shares issued (in shares)                 183,731      
Warrants issued (in shares)                 761,079      
Warrants to acquire shares of common stock   1             1      
Warrants exercisable                 508,159      
Securities Purchase Agreement | Scenario two | One Investor                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares   $ 0.1696             $ 0.1696      
Warrants exercise price, after reverse stock splits | $ / shares   $ 152.64             $ 152.64      
Securities Purchase Agreement | Scenario three                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants term             4 years 6 months          
Proceeds from issuance of shares and warrants | $                 $ 254,962,776      
Fair value of common stock warrants | $             $ 20,704,136     $ 64,739,175    
Convertible notes                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants term                       5 years
Proceeds from issuance of notes payable | $         $ 150,000,000              
Prefunded Warrants | Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercisable   54,962                    
Warrants to purchase to common stock   1             1      
Prefunded Warrants | Securities Purchase Agreement | Scenario three                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Exercisable on a cash-less basis                   0    
Preferred D Warrants | Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares     $ 0.1                  
Proceeds from issuance of shares and warrants | $     $ 45,000,000                  
Preferred C Warrants 2021                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares             $ 8.834          
Warrants exercise price, after reverse stock splits | $ / shares             198,765          
Preferred C Warrants 2022                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants               132        
Preferred D Warrants 2022                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares             1.27          
Warrants exercise price, after reverse stock splits | $ / shares             $ 28,575          
Percentage of warrants exercisable for common stock             185.00%   110.00%      
Warrants term             5 years          
Warrants issued (in shares)           263            
Exercised on a cash-less basis               10,182        
Fair value of common stock warrants | $           $ 55,398,551            
Preferred D Warrants 2022 | Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price, after reverse stock splits | $ / shares     $ 2,250                  
Warrants issued (in shares)     37,000                  
Exercisable on a cash-less basis                 147,672      
Fair value of common stock warrants | $     $ 73,260,454                  
Preferred D Warrants 2022 | Securities Purchase Agreement | Scenario one                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants issued (in shares)   27,671                    
Preferred D Warrants 2022 | Securities Purchase Agreement | Scenario three                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Exercised on a cash-less basis             2,020,152     2,194,413    
Exercisable on a cash-less basis                   382,436    
Preferred D Warrants 2022 | Convertible notes                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants issued (in shares)       43,616                
Exercisable on a cash-less basis                 93,664      
Qiantu Warrants                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants exercise price | $ / shares                     $ 234  
Number of intellectual property agreement | item 2                      
Period to use the license under intellectual property agreement 5 years                      
Market price of the Company's common shares 110.00%                      
Fair value of warrants | $ $ 6,814,000           $ 10,485     $ 124,133    
Qiantu Warrants | Maximum                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants to acquire shares of common stock 3,334                      
Series D Preferred Stock                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Number of shares issued (in shares)           79,926,925            
Investment right amount | $   $ 100,000,000             $ 100,000,000      
Series D Preferred Stock | Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Number of shares issued (in shares)     273,363,635                  
Common Stock | Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Number of shares issued (in shares)   60,778                    
Common Stock | Securities Purchase Agreement | Scenario one                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Number of shares issued (in shares)   14,957                    
Common Stock | Securities Purchase Agreement | Scenario three                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Warrants to acquire shares of common stock                   1,438,009    
Common Stock | Series D Preferred Stock | Securities Purchase Agreement                        
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS                        
Conversion of stock, shares issued     7,851